Increased MICA/B secretion is seen in the context of chemotherapy-induced senescence in neuroblastoma cells, and leads to increased MICA/B binding to surrounding natural killer cells, inhibiting these cells and allowing immune evasion [80]. This evidence concerns the gene MICA and neuroblastoma.